Pediatric Translational Cancer Research Grant

V Foundation
Application Due Date
for consideration, please send 1 page abstract and NIH biosketch sent to Sarah Laye @ no later than 5/5/23
Brief Description

PURPOSE OF AWARD: This Request for Applications (RFA) is specifically for pediatric cancer research through the Translational grant mechanism. Applicants may propose pediatric cancer research that moves a novel strategy from the laboratory into a human clinical trial or uses specimens from a clinical trial to develop biomarkers or mechanisms. The research should apply in some direct way to human beings within the time frame of less than 3 years from the end of the grant. If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new clinical trial.